S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
AAPL   261.81 (-0.15%)
FB   194.47 (+2.56%)
MSFT   147.07 (+0.66%)
GOOGL   1,297.21 (-0.08%)
AMZN   1,778.00 (+0.36%)
CGC   19.25 (-5.17%)
NVDA   209.61 (+0.69%)
MU   46.90 (+1.38%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
TSLA   349.93 (+1.40%)
T   39.17 (-0.51%)
AMD   36.71 (+1.10%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
PRI   129.95 (+0.56%)
NFLX   292.01 (-0.74%)
BAC   33.09 (-0.27%)
GILD   64.32 (-0.50%)
DIS   138.58 (+1.35%)
S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
AAPL   261.81 (-0.15%)
FB   194.47 (+2.56%)
MSFT   147.07 (+0.66%)
GOOGL   1,297.21 (-0.08%)
AMZN   1,778.00 (+0.36%)
CGC   19.25 (-5.17%)
NVDA   209.61 (+0.69%)
MU   46.90 (+1.38%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
TSLA   349.93 (+1.40%)
T   39.17 (-0.51%)
AMD   36.71 (+1.10%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
PRI   129.95 (+0.56%)
NFLX   292.01 (-0.74%)
BAC   33.09 (-0.27%)
GILD   64.32 (-0.50%)
DIS   138.58 (+1.35%)
Log in

Cardlytics Stock Price, Forecast & Analysis (NASDAQ:CDLX)

$39.85
+0.21 (+0.53 %)
(As of 11/12/2019 04:00 PM ET)
Today's Range
$39.27
Now: $39.85
$40.54
50-Day Range
$32.81
MA: $37.12
$41.63
52-Week Range
$9.80
Now: $39.85
$42.19
Volume548,600 shs
Average Volume314,189 shs
Market Capitalization$909.70 million
P/E RatioN/A
Dividend YieldN/A
Beta1.56
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. Read More…

Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150.68 million
Book Value$2.56 per share

Profitability

Net Income$-53,040,000.00

Miscellaneous

EmployeesN/A
Market Cap$909.70 million
Next Earnings Date11/12/2019 (Confirmed)
OptionableNot Optionable

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.


Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

How were Cardlytics' earnings last quarter?

Cardlytics Inc (NASDAQ:CDLX) posted its earnings results on Tuesday, August, 14th. The company reported ($0.21) earnings per share for the quarter, beating the consensus estimate of ($0.53) by $0.32. The firm earned $35.57 million during the quarter, compared to analyst estimates of $34.89 million. Cardlytics had a negative net margin of 19.60% and a negative return on equity of 66.01%. Cardlytics's revenue for the quarter was up 8.4% on a year-over-year basis. View Cardlytics' Earnings History.

When is Cardlytics' next earnings date?

Cardlytics is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Cardlytics.

What price target have analysts set for CDLX?

7 analysts have issued 12 month target prices for Cardlytics' stock. Their forecasts range from $26.00 to $43.00. On average, they anticipate Cardlytics' stock price to reach $33.67 in the next twelve months. This suggests that the stock has a possible downside of 15.5%. View Analyst Price Targets for Cardlytics.

What is the consensus analysts' recommendation for Cardlytics?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cardlytics.

What are Wall Street analysts saying about Cardlytics stock?

Here are some recent quotes from research analysts about Cardlytics stock:
  • 1. According to Zacks Investment Research, "Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The purchase data includes debit, credit and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions. Cardlytics, Inc. is based in ATLANTA, United States. " (10/31/2019)
  • 2. SunTrust Banks, Inc. analysts commented, "We hosted Cardlytics’ CEO and Co-Founder, Scott Grimes, and COO and Co- Founder, Lynne Laube, at our 6th annual internet and digital media conference for a fireside chat." (5/21/2019)

Has Cardlytics been receiving favorable news coverage?

News coverage about CDLX stock has been trending very negative on Tuesday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cardlytics earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Cardlytics.

Are investors shorting Cardlytics?

Cardlytics saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 3,730,000 shares, an increase of 9.4% from the September 30th total of 3,410,000 shares. Based on an average daily volume of 479,200 shares, the days-to-cover ratio is presently 7.8 days. Currently, 18.3% of the company's stock are sold short. View Cardlytics' Current Options Chain.

Who are some of Cardlytics' key competitors?

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Caterpillar (CAT), Okta (OKTA), Trade Desk (TTD), Alibaba Group (BABA), Shopify (SHOP), Square (SQ), Store Capital (STOR), Baidu (BIDU), Nutanix (NTNX) and Roku (ROKU).

Who are Cardlytics' key executives?

Cardlytics' management team includes the folowing people:
  • Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 56)
  • Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
  • Mr. David Evans, CFO & Head of Corp. Devel.
  • Mr. Sathish Gaddipati, Chief Technology Officer (Age 52)
  • Mr. Kirk L. Somers, Chief Legal & People Officer (Age 54)

When did Cardlytics IPO?

(CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Kornitzer Capital Management Inc. KS (0.81%), Tygh Capital Management Inc. (0.53%), Hancock Whitney Corp (0.49%), Covey Capital Advisors LLC (0.26%), CIBC Private Wealth Group LLC (0.15%) and Columbus Circle Investors (0.11%). Company insiders that own Cardlytics stock include Aimia Inc, Bryce Youngren, Clifford Sosin, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Institutional Ownership Trends for Cardlytics.

Which institutional investors are selling Cardlytics stock?

CDLX stock was sold by a variety of institutional investors in the last quarter, including Tygh Capital Management Inc. and CIBC Private Wealth Group LLC. Company insiders that have sold Cardlytics company stock in the last year include Aimia Inc, Bryce Youngren, David Thomas Evans, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman. View Insider Buying and Selling for Cardlytics.

Which institutional investors are buying Cardlytics stock?

CDLX stock was purchased by a variety of institutional investors in the last quarter, including Hancock Whitney Corp, Kornitzer Capital Management Inc. KS, Covey Capital Advisors LLC, Columbus Circle Investors, D.A. Davidson & CO., Brave Asset Management Inc., Capital Investment Advisors LLC and Russell Investments Group Ltd.. Company insiders that have bought Cardlytics stock in the last two years include Clifford Sosin, David Thomas Evans and Scott D Grimes. View Insider Buying and Selling for Cardlytics.

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Cardlytics' stock price today?

One share of CDLX stock can currently be purchased for approximately $39.85.

How big of a company is Cardlytics?

Cardlytics has a market capitalization of $909.70 million and generates $150.68 million in revenue each year. The company earns $-53,040,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. View Additional Information About Cardlytics.

What is Cardlytics' official website?

The official website for Cardlytics is http://www.cardlytics.com/.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]


MarketBeat Community Rating for Cardlytics (NASDAQ CDLX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  150 (Vote Outperform)
Underperform Votes:  198 (Vote Underperform)
Total Votes:  348
MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe CDLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CDLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel